Pharmaceutical Excipient Albumin - Global and China Top Players Market Share and Ranking 2023
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
According to Latest Study, the global market for Pharmaceutical Excipient Albumin should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By country, China accounted for percent of the global market last year and China’s market share increased from percent to percent. China Pharmaceutical Excipient Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029. The United States Pharmaceutical Excipient Albumin market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
By segment, Cell Culture Media grew percent to account for percent of the total market sales, and Medical Supplements grew percent.
Albumin is a water-soluble globular protein produced in the liver. It accounts for 50% of blood plasma proteins. These play a vital role in regulating blood volume and act as transporters for molecules such as few hormones, bile salts, and ions. Albumin is commonly used as blood volumizer in rare diseases, burns, shocks, liver conditions, and other blood loss trauma and surgeries
This report studies and analyses global Pharmaceutical Excipient Albumin status and future trends, helps the client to determine the Pharmaceutical Excipient Albumin market size of the total market opportunity by Type, by Application, by company, and by region & country. This report is a detailed and comprehensive analysis of the world market for Pharmaceutical Excipient Albumin, and provides market size (in K Units & US$ million) and Year-over-Year growth, considering 2022 as the base year.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
To assess the competitive environment within the market including supplier revenue, market share, and company profiles.
Highlights
(1) Global Pharmaceutical Excipient Albumin market size, history data 2018-2023, and forecast data 2024 -2029, (US$ million) & (K Units)
(2) Global Pharmaceutical Excipient Albumin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(3) China Pharmaceutical Excipient Albumin sales, revenue, price by company, market share and industry ranking 2018-2023, (US$ million) & (K Units)
(4) Global Pharmaceutical Excipient Albumin key consuming regions, consumption quantity, consumption value and demand structure
(5) Global Pharmaceutical Excipient Albumin key producing regions, capacity, production, and year over year growth
(6) Pharmaceutical Excipient Albumin industry chains, upstream, midstream and downstream
Market segment by players, this report covers
CSL
Grifols
Takeda
Octapharma
Hualan Bio
CBPO
Shanghai RAAS
Kedrion
LFB Group
Albumedix
Biotest
Merck
Ventria (InVitria)
HiMedia
Market segment by Type, covers
Human Serum Albumin
Recombinant Albumin
Market segment by Application, can be divided into
Cell Culture Media
Medical Supplements
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Report Includes:
Chapter 1: to describe Pharmaceutical Excipient Albumin product scope, global sales quantity, value and average price, China sales quantity, value and average price, development opportunities, challenges, trends, and policies.
Chapter 2: Global Pharmaceutical Excipient Albumin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 3: China Pharmaceutical Excipient Albumin market share and ranking of major manufacturers, sales quantity, revenue, average price, 2018-2023
Chapter 4: Global key producing regions of Pharmaceutical Excipient Albumin, percent & CAGR, 2018-2029
Chapter 5: Pharmaceutical Excipient Albumin industry chain, upstream, medium-stream, and downstream.
Chapter 6: Segment by Type, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 7: Segment by Application, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 8: Segment in regional level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 9: Segment in country level, sales quantity, average price, consumption value, percent & CAGR, 2018-2029
Chapter 10: Company profile, introducing the basic situation of the main companies in the market in detail, including product specifications, application, recent development, sales quantity, average price, revenue, gross margin.
Chapter 11: Conclusions
1 Market Overview
1.1 Pharmaceutical Excipient Albumin Definition
1.2 Global Pharmaceutical Excipient Albumin Market Size and Forecast
1.2.1 By Consumption Value, Global Pharmaceutical Excipient Albumin Market Size，2018-2029
1.2.2 By Sales Quantity, Global Pharmaceutical Excipient Albumin Market Size，2018-2029
1.2.3 Global Pharmaceutical Excipient Albumin Average Selling Price (ASP)，2018-2029
1.3 China Pharmaceutical Excipient Albumin Market Size and Forecast
1.3.1 By Consumption Value, China Pharmaceutical Excipient Albumin Market Size，2018-2029
1.3.2 By Sales Quantity, China Pharmaceutical Excipient Albumin Market Size，2018-2029
1.3.3 China Pharmaceutical Excipient Albumin Average Selling Price (ASP)， 2018-2029
1.4 Share of China Pharmaceutical Excipient Albumin Market with Respect to the Global Market
1.4.1 By Consumption Value, China Pharmaceutical Excipient Albumin Market Share in Global, 2018-2029
1.4.2 By Sales Quantity, China Pharmaceutical Excipient Albumin Market Share in Global, 2018-2029
1.4.3 Pharmaceutical Excipient Albumin Market Size: China VS Global, 2018-2029
1.5 Pharmaceutical Excipient Albumin Market Dynamics
1.5.1 Pharmaceutical Excipient Albumin Market Drivers
1.5.2 Pharmaceutical Excipient Albumin Market Restraints
1.5.3 Pharmaceutical Excipient Albumin Industry Trends
1.5.4 Pharmaceutical Excipient Albumin Industry Policy
2 Global Leading Manufacturers and Market Share
2.1 By Revenue of Pharmaceutical Excipient Albumin, Global Market Share by Company, 2018-2023
2.2 By Sales Quantity of Pharmaceutical Excipient Albumin, Global Market Share by Company, 2018-2023
2.3 Pharmaceutical Excipient Albumin Average Selling Price (ASP) by Company, 2018-2023
2.4 Global Pharmaceutical Excipient Albumin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
2.5 Global Pharmaceutical Excipient Albumin Concentration Ratio
2.6 Global Pharmaceutical Excipient Albumin Mergers & Acquisitions, Expansion Plans
2.7 Global Pharmaceutical Excipient Albumin Manufacturers Product Type
2.8 Head Office and Pharmaceutical Excipient Albumin Production Site of Key Manufacturer
2.9 Pharmaceutical Excipient Albumin Capacity of Major Manufacturers and Future Plan
3 China Leading Manufacturers and Market Share
3.1 By Revenue of Pharmaceutical Excipient Albumin, China Market Share by Company, 2018-2023
3.2 By Sales Quantity of Pharmaceutical Excipient Albumin, China Market Share by Company, 2018-2023
3.3 China Pharmaceutical Excipient Albumin Participants, Market Position (Tier 1, Tier 2, and Tier 3)
4 Global Producing Regions
4.1 Global Pharmaceutical Excipient Albumin Capacity, Output and Capacity Utilization, 2018-2029
4.2 Global Pharmaceutical Excipient Albumin Capacity by Region
4.3 Global Pharmaceutical Excipient Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029
4.4 Global Pharmaceutical Excipient Albumin Production by Region, 2018-2029
4.5 Global Pharmaceutical Excipient Albumin Production Market Share & Forecast by Region, 2018-2029
5 Industry Chain Analysis
5.1 Pharmaceutical Excipient Albumin Industry Chain
5.2 Pharmaceutical Excipient Albumin Upstream Analysis
5.2.1 Pharmaceutical Excipient Albumin Core Raw Materials
5.2.2 Main Manufacturers of Pharmaceutical Excipient Albumin Core Raw Materials
5.3 Midstream Analysis
5.4 Downstream Analysis
5.5 Pharmaceutical Excipient Albumin Production Mode
5.6 Pharmaceutical Excipient Albumin Procurement Model
5.7 Pharmaceutical Excipient Albumin Industry Sales Model and Sales Channels
5.7.1 Pharmaceutical Excipient Albumin Sales Model
5.7.2 Pharmaceutical Excipient Albumin Typical Distributors
6 Sights by Type
6.1 Pharmaceutical Excipient Albumin Classification
6.1.1 Human Serum Albumin
6.1.2 Recombinant Albumin
6.2 By Type, Global Pharmaceutical Excipient Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029
6.3 By Type, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029
6.4 By Type, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029
6.5 By Type, Global Pharmaceutical Excipient Albumin Average Selling Price (ASP), 2018-2029
7 Sights by Application
7.1 Pharmaceutical Excipient Albumin Segment by Application
7.1.1 Cell Culture Media
7.1.2 Medical Supplements
7.2 By Application, Global Pharmaceutical Excipient Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029
7.3 By Application, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029
7.4 By Application, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029
7.5 By Application, Global Pharmaceutical Excipient Albumin Price, 2018-2029
8 Sales Sights by Region
8.1 By Region, Global Pharmaceutical Excipient Albumin Consumption Value, 2018 VS 2022 VS 2029
8.2 By Region, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029
8.3 By Region, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029
8.4 North America
8.4.1 North America Pharmaceutical Excipient Albumin & Forecasts, 2018-2029
8.4.2 By Country, North America Pharmaceutical Excipient Albumin Market Size Market Share
8.5 Europe
8.5.1 Europe Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.5.2 By Country, Europe Pharmaceutical Excipient Albumin Market Size Market Share
8.6 Asia Pacific
8.6.1 Asia Pacific Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.6.2 By Country/Region, Asia Pacific Pharmaceutical Excipient Albumin Market Size Market Share
8.7 South America
8.7.1 South America Pharmaceutical Excipient Albumin Market Size & Forecasts, 2018-2029
8.7.2 By Country, South America Pharmaceutical Excipient Albumin Market Size Market Share
8.8 Middle East & Africa
9 Sales Sights by Country Level
9.1 By Country, Global Pharmaceutical Excipient Albumin Market Size & CAGR, 2018 VS 2022 VS 2029
9.2 By Country, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029
9.3 By Country, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029
9.4 U.S.
9.4.1 U.S. Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.4.2 By Type, U.S. Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.4.3 By Application, U.S. Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.5 Europe
9.5.1 Europe Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.5.2 By Type, Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.5.3 By Application, Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.6 China
9.6.1 China Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.6.2 By Type, China Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.6.3 By Application, China Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.7 Japan
9.7.1 Japan Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.7.2 By Type, Japan Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.7.3 By Application, Japan Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.8 South Korea
9.8.1 South Korea Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.8.2 By Type, South Korea Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.8.3 By Application, South Korea Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.9 Southeast Asia
9.9.1 Southeast Asia Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.9.2 By Type, Southeast Asia Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.9.3 By Application, Southeast Asia Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.10 India
9.10.1 India Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.10.2 By Type, India Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.10.3 By Application, India Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.11 Middle East & Africa
9.11.1 Middle East & Africa Pharmaceutical Excipient Albumin Market Size, 2018-2029
9.11.2 By Type, Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
9.11.3 By Application, Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
10 Manufacturers Profile
10.1 CSL
10.1.1 CSL Company Information, Head Office, Market Area, and Industry Position
10.1.2 CSL Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.1.3 CSL Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.1.4 CSL Company Profile and Main Business
10.1.5 CSL Recent Developments
10.2 Grifols
10.2.1 Grifols Company Information, Head Office, Market Area, and Industry Position
10.2.2 Grifols Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.2.3 Grifols Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.2.4 Grifols Company Profile and Main Business
10.2.5 Grifols Recent Developments
10.3 Takeda
10.3.1 Takeda Company Information, Head Office, Market Area, and Industry Position
10.3.2 Takeda Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.3.3 Takeda Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.3.4 Takeda Company Profile and Main Business
10.3.5 Takeda Recent Developments
10.4 Octapharma
10.4.1 Octapharma Company Information, Head Office, Market Area, and Industry Position
10.4.2 Octapharma Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.4.3 Octapharma Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.4.4 Octapharma Company Profile and Main Business
10.4.5 Octapharma Recent Developments
10.5 Hualan Bio
10.5.1 Hualan Bio Company Information, Head Office, Market Area, and Industry Position
10.5.2 Hualan Bio Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.5.3 Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.5.4 Hualan Bio Company Profile and Main Business
10.5.5 Hualan Bio Recent Developments
10.6 CBPO
10.6.1 CBPO Company Information, Head Office, Market Area, and Industry Position
10.6.2 CBPO Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.6.3 CBPO Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.6.4 CBPO Company Profile and Main Business
10.6.5 CBPO Recent Developments
10.7 Shanghai RAAS
10.7.1 Shanghai RAAS Company Information, Head Office, Market Area, and Industry Position
10.7.2 Shanghai RAAS Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.7.3 Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.7.4 Shanghai RAAS Company Profile and Main Business
10.7.5 Shanghai RAAS Recent Developments
10.8 Kedrion
10.8.1 Kedrion Company Information, Head Office, Market Area, and Industry Position
10.8.2 Kedrion Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.8.3 Kedrion Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.8.4 Kedrion Company Profile and Main Business
10.8.5 Kedrion Recent Developments
10.9 LFB Group
10.9.1 LFB Group Company Information, Head Office, Market Area, and Industry Position
10.9.2 LFB Group Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.9.3 LFB Group Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.9.4 LFB Group Company Profile and Main Business
10.9.5 LFB Group Recent Developments
10.10 Albumedix
10.10.1 Albumedix Company Information, Head Office, Market Area, and Industry Position
10.10.2 Albumedix Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.10.3 Albumedix Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.10.4 Albumedix Company Profile and Main Business
10.10.5 Albumedix Recent Developments
10.11 Biotest
10.11.1 Biotest Company Information, Head Office, Market Area, and Industry Position
10.11.2 Biotest Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.11.3 Biotest Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.11.4 Biotest Company Profile and Main Business
10.11.5 Biotest Recent Developments
10.12 Merck
10.12.1 Merck Company Information, Head Office, Market Area, and Industry Position
10.12.2 Merck Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.12.3 Merck Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.12.4 Merck Company Profile and Main Business
10.12.5 Merck Recent Developments
10.13 Ventria (InVitria)
10.13.1 Ventria (InVitria) Company Information, Head Office, Market Area, and Industry Position
10.13.2 Ventria (InVitria) Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.13.3 Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.13.4 Ventria (InVitria) Company Profile and Main Business
10.13.5 Ventria (InVitria) Recent Developments
10.14 HiMedia
10.14.1 HiMedia Company Information, Head Office, Market Area, and Industry Position
10.14.2 HiMedia Pharmaceutical Excipient Albumin Models, Specifications, and Application
10.14.3 HiMedia Pharmaceutical Excipient Albumin Sales Quantity, Revenue, Price and Gross Margin, 2018-2023
10.14.4 HiMedia Company Profile and Main Business
10.14.5 HiMedia Recent Developments
11 Conclusion
12 Appendix
12.1 Research Methodology
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Market Estimation Model
12.4 Disclaimer
Table 1. Pharmaceutical Excipient Albumin Consumption Value & CAGR: China VS Global, 2018-2029, US$ Million
Table 2. Pharmaceutical Excipient Albumin Market Restraints
Table 3. Pharmaceutical Excipient Albumin Market Trends
Table 4. Pharmaceutical Excipient Albumin Industry Policy
Table 5. Global Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 6. Global Pharmaceutical Excipient Albumin Revenue Share by Company, 2018-2023, Ranked by Data of 2022
Table 7. Global Pharmaceutical Excipient Albumin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 8. Global Pharmaceutical Excipient Albumin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 9. Global Pharmaceutical Excipient Albumin Average Selling Price (ASP) by Company, (2018-2023) & (US$/Unit)
Table 10. Global Pharmaceutical Excipient Albumin Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 11. Global Pharmaceutical Excipient Albumin Mergers & Acquisitions, Expansion Plans
Table 12. Global Pharmaceutical Excipient Albumin Manufacturers Product Type
Table 13. Head Office and Pharmaceutical Excipient Albumin Production Site of Key Manufacturer
Table 14. Pharmaceutical Excipient Albumin Capacity of Major Manufacturers and Future Plan
Table 15. China Pharmaceutical Excipient Albumin Revenue by Company, 2018-2023, US$ million, Ranked Based on Revenue in 2022
Table 16. China Pharmaceutical Excipient Albumin Sales Quantity by Company, (2018-2023) & (K Units), Ranked Based on Sales in 2022
Table 17. China Pharmaceutical Excipient Albumin Sales Quantity by Company, 2018-2023, Ranked by Data of 2022
Table 18. Global Pharmaceutical Excipient Albumin Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)
Table 19. Global Pharmaceutical Excipient Albumin Production by Region, 2018-2023, (K Units)
Table 20. Global Pharmaceutical Excipient Albumin Production Forecast by Region, 2024-2029, (K Units)
Table 21. Global Key Players of Pharmaceutical Excipient Albumin Upstream (Raw Materials)
Table 22. Global Pharmaceutical Excipient Albumin Typical Customers
Table 23. Pharmaceutical Excipient Albumin Typical Distributors
Table 24. By Type, Global Pharmaceutical Excipient Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 25. By Application, Global Pharmaceutical Excipient Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 26. By Region, Global Pharmaceutical Excipient Albumin Consumption Value, 2018 VS 2022 VS 2029, US$ Million
Table 27. By Region, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029, US$ Million
Table 28. By Region, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Table 29. By Country, Global Pharmaceutical Excipient Albumin Consumption Value & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 30. By Country, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029, US$ Million
Table 31. By Country, Global Pharmaceutical Excipient Albumin Consumption Value Market Share, 2018-2029
Table 32. By Country, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Table 33. By Country, Global Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2018-2029
Table 34. CSL Company Information, Head Office, Market Area, and Industry Position
Table 35. CSL Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 36. CSL Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 37. CSL Company Profile and Main Business
Table 38. CSL Recent Developments
Table 39. Grifols Company Information, Head Office, Market Area, and Industry Position
Table 40. Grifols Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 41. Grifols Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 42. Grifols Company Profile and Main Business
Table 43. Grifols Recent Developments
Table 44. Takeda Company Information, Head Office, Market Area, and Industry Position
Table 45. Takeda Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 46. Takeda Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 47. Takeda Company Profile and Main Business
Table 48. Takeda Recent Developments
Table 49. Octapharma Company Information, Head Office, Market Area, and Industry Position
Table 50. Octapharma Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 51. Octapharma Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 52. Octapharma Company Profile and Main Business
Table 53. Octapharma Recent Developments
Table 54. Hualan Bio Company Information, Head Office, Market Area, and Industry Position
Table 55. Hualan Bio Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 56. Hualan Bio Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 57. Hualan Bio Company Profile and Main Business
Table 58. Hualan Bio Recent Developments
Table 59. CBPO Company Information, Head Office, Market Area, and Industry Position
Table 60. CBPO Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 61. CBPO Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 62. CBPO Company Profile and Main Business
Table 63. CBPO Recent Developments
Table 64. Shanghai RAAS Company Information, Head Office, Market Area, and Industry Position
Table 65. Shanghai RAAS Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 66. Shanghai RAAS Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 67. Shanghai RAAS Company Profile and Main Business
Table 68. Shanghai RAAS Recent Developments
Table 69. Kedrion Company Information, Head Office, Market Area, and Industry Position
Table 70. Kedrion Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 71. Kedrion Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 72. Kedrion Company Profile and Main Business
Table 73. Kedrion Recent Developments
Table 74. LFB Group Company Information, Head Office, Market Area, and Industry Position
Table 75. LFB Group Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 76. LFB Group Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 77. LFB Group Company Profile and Main Business
Table 78. LFB Group Recent Developments
Table 79. Albumedix Company Information, Head Office, Market Area, and Industry Position
Table 80. Albumedix Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 81. Albumedix Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 82. Albumedix Company Profile and Main Business
Table 83. Albumedix Recent Developments
Table 84. Biotest Company Information, Head Office, Market Area, and Industry Position
Table 85. Biotest Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 86. Biotest Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 87. Biotest Company Profile and Main Business
Table 88. Biotest Recent Developments
Table 89. Merck Company Information, Head Office, Market Area, and Industry Position
Table 90. Merck Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 91. Merck Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 92. Merck Company Profile and Main Business
Table 93. Merck Recent Developments
Table 94. Ventria (InVitria) Company Information, Head Office, Market Area, and Industry Position
Table 95. Ventria (InVitria) Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 96. Ventria (InVitria) Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 97. Ventria (InVitria) Company Profile and Main Business
Table 98. Ventria (InVitria) Recent Developments
Table 99. HiMedia Company Information, Head Office, Market Area, and Industry Position
Table 100. HiMedia Pharmaceutical Excipient Albumin Models, Specifications, and Application
Table 101. HiMedia Pharmaceutical Excipient Albumin Sales Quantity (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023
Table 102. HiMedia Company Profile and Main Business
Table 103. HiMedia Recent Developments
List of Figures
Figure 1. Pharmaceutical Excipient Albumin Picture
Figure 2. Global Pharmaceutical Excipient Albumin Consumption Value, (US$ million) & (2018-2029)
Figure 3. Global Pharmaceutical Excipient Albumin Sales Quantity, (K Units) & (2018-2029)
Figure 4. Global Pharmaceutical Excipient Albumin Average Selling Price (ASP), (2018-2029) & (US$/Unit)
Figure 5. China Pharmaceutical Excipient Albumin Consumption Value, (US$ million) & (2018-2029)
Figure 6. China Pharmaceutical Excipient Albumin Sales Quantity (K Units) & (2018-2029)
Figure 7. China Pharmaceutical Excipient Albumin Average Selling Price (ASP), (US$/Unit) & (2018-2029)
Figure 8. By Consumption Value, China Pharmaceutical Excipient Albumin Market Share of Global, 2018-2029
Figure 9. By Sales Quantity, China Pharmaceutical Excipient Albumin Market Share of Global, 2018-2029
Figure 10. Global Pharmaceutical Excipient Albumin Market Share by Company, (Tier 1, Tier 2, and Tier 3), 2022
Figure 11. China Pharmaceutical Excipient Albumin Key Participants, Market Share, 2022
Figure 12. Global Pharmaceutical Excipient Albumin Capacity, Production and Capacity Utilization, 2018-2029
Figure 13. Global Pharmaceutical Excipient Albumin Capacity Market Share by Region, 2022 VS 2029
Figure 14. Global Pharmaceutical Excipient Albumin Production Market Share & Forecast by Region, 2018-2029
Figure 15. Pharmaceutical Excipient Albumin Industry Chain
Figure 16. Pharmaceutical Excipient Albumin Procurement Model
Figure 17. Pharmaceutical Excipient Albumin Sales Model
Figure 18. Pharmaceutical Excipient Albumin Sales Channels, Direct Sales, and Distribution
Figure 19. Human Serum Albumin
Figure 20. Recombinant Albumin
Figure 21. By Type, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029, US$ Million
Figure 22. By Type, Global Pharmaceutical Excipient Albumin Consumption Value Market Share, 2018-2029
Figure 23. By Type, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 24. By Type, Global Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2018-2029
Figure 25. By Type, Global Pharmaceutical Excipient Albumin Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 26. Cell Culture Media
Figure 27. Medical Supplements
Figure 28. By Application, Global Pharmaceutical Excipient Albumin Consumption Value, 2018-2029, US$ Million
Figure 29. By Application, Global Pharmaceutical Excipient Albumin Consumption Value Market Share, 2018-2029
Figure 30. By Application, Global Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 31. By Application, Global Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2018-2029
Figure 32. By Application, Global Pharmaceutical Excipient Albumin Average Selling Price (ASP), 2018-2029, (US$/Unit)
Figure 33. By Region, Global Pharmaceutical Excipient Albumin Consumption Value Market Share, 2018-2029
Figure 34. By Region, Global Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2018-2029
Figure 35. North America Pharmaceutical Excipient Albumin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 36. By Country, North America Pharmaceutical Excipient Albumin Consumption Value Market Share, 2022
Figure 37. Europe Pharmaceutical Excipient Albumin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 38. By Country, Europe Pharmaceutical Excipient Albumin Consumption Value Market Share, 2022
Figure 39. Asia Pacific Pharmaceutical Excipient Albumin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 40. By Country/Region, Asia Pacific Pharmaceutical Excipient Albumin Consumption Value Market Share, 2022
Figure 41. South America Pharmaceutical Excipient Albumin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 42. By Country, South America Pharmaceutical Excipient Albumin Consumption Value Market Share, 2022
Figure 43. Middle East & Africa Pharmaceutical Excipient Albumin Consumption Value & Forecasts, 2018-2029, US$ Million
Figure 44. U.S. Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 45. By Type, U.S. Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 46. By Application, U.S. Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 47. Europe Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 48. By Type, Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 49. By Application, Europe Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 50. China Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 51. By Type, China Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 52. By Application, China Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 53. Japan Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 54. By Type, Japan Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 55. By Application, Japan Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 56. South Korea Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 57. By Type, South Korea Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 58. By Application, South Korea Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 59. Southeast Asia Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 60. By Type, Southeast Asia Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 61. By Application, Southeast Asia Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 62. India Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 63. By Type, India Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 64. By Application, India Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 65. Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity, 2018-2029, (K Units)
Figure 66. By Type, Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 67. By Application, Middle East & Africa Pharmaceutical Excipient Albumin Sales Quantity Market Share, 2022 VS 2029
Figure 68. Research Methodology
Figure 69. Breakdown of Primary Interviews
Figure 70. Bottom-up and Top-down Approaches
Figure 71. Top-down Approaches
Research Methodology:
Pharmaceutical Excipient Albumin Global and China Top Players Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|